Pacira BioSciences Inc
(NASDAQ:PCRX)
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.
top performing PCRX trades
-55.00%
Recent Trades
Largest Trades
Top Performing
Largest Traders
Most Active Traders
Recent Trades
View the most recent Pacira BioSciences trades made by congress members.
Tom MalinowskiHouse (D-NJ) | $1K - $15K | stock | Purchase | Jun 23, 2021 | May 06, 2021 | House |